Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Cited by (720)

Items 101–200 of 720

1. Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma
   Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Jae‐Soo Koh, Won Seok Song, Wan Hyeong Cho, Chang‐Bae Kong, Sang Moo Lim · 2020 · EJNMMI Research
2. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
   Azeem Tariq Malik, John H. Alexander, Joel L. Mayerson, Safdar N. Khan, Thomas J. Scharschmidt · 2020 · Clinical Orthopaedics and Related Research
3. Aberrant Activation of Wound-Healing Programs within the Metastatic Niche Facilitates Lung Colonization by Osteosarcoma Cells
   James Brandon Reinecke, Leyre Jimenez Garcia, Amy C. Gross, Maren Cam, Matthew V. Cannon, Matthew J. Gust, Jeffrey P. Sheridan, Berkley E. Gryder, Ruben Dries, Ryan David Roberts · 2024 · Clinical Cancer Research
4. Towards precision medicine: design considerations for nanozymes in tumor treatment
   Xinqiao Li, Jinpeng Hu, Q Zhao, Weifeng Yao, Zhitao Jing, Zining Jin · 2024 · Journal of Translational Medicine
5. Chondromyxoid fibroma-like osteosarcoma: a case series and literature review
   Jingyu Zhong, Liping Si, Jia Geng, Yue Xing, Yangfan Hu, Qiong Jiao, Huizhen Zhang, Weiwu Yao · 2020 · BMC Musculoskeletal Disorders
6. 223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy
   Pete M. Anderson, Jacob G. Scott, Shireen Parsai, Stacey G. Zahler, Sarah E. Worley, Sankaran Shrikanthan, Vivek Subbiah, Erin Sennett Murphy · 2020 · ESMO Open
7. Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases
   Cong Ma, Ruizhen Li, Ronghui Yu, Jingjing Guo, Jianyun Xu, Xuhui Yuan, Jianfeng Guo · 2022 · BMC Cancer
8. The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
   Yanjiao Wu, Zhiyun Wang, Jianlin Shen, Wei Yan, Shurong Xiang, Huan Liu, Wenhua Huang · 2022 · Human Genomics
9. CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
   Jun Cheng, Yan Zhang, Rongjun Wan, Jun Zhou, Xin Wu, Qizhi Fan, Jingpeng He, Wei Tan, Youwen Deng · 2022 · Frontiers in Oncology
10. Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
    Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A.J. Verdonschot, Dunja Maroeska W.M. Te Loo, Marieke J. H. Coenen · 2022 · BMC Cancer
11. Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database
    Kathryn E. Gallaway, Junho Ahn, Alexandra K. Callan · 2020 · Journal of Oncology
12. Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center
    Richard E. Evenhuis, Ibtissam Acem, Anja J. Rueten‐Budde, Diederik S.A. Karis, Marta F. Fiocco, Desirée M. J. Dorleijn, Frank M. Speetjens, Jakob Anninga, Hans A. J. Gelderblom, Michiel A. J. van de Sande · 2021 · Cancers
13. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value
    Hua Liu, Guangzhen Qin, Yanan Ji, Xiaojian Wang, Hailin Bao, Xiaojun Guan, Aichun Wei, Zhigang Cai · 2021 · Journal of Orthopaedic Surgery and Research
14. The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma
    Tianyu Feng, Zhongkai Zhu, Yaqian Jin, Hao Wang, Xiaohan Mao, Dan Liu, Yiling Li, Lixia Lu, Guowei Zuo · 2019 · Oncology Reports
15. Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Yongheng Liu, Guanghao Li, Jinyan_feng@126.com Feng, Lili Li, Yan-ting Yann Zhang, Xiaoyu Huang, Xianfu Wei, Yao Xu, Ming Liu, Xianfu Wei et al. · 2022 · Cancer Cell International
16. Expression and Role of TRIM2 in Human Diseases
    Maolin Xiao, Jianjun Li, Qingyuan Liu, Xiangbiao He, Zongke Yang, Delin Wang · 2022 · BioMed Research International
17. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)
    Stefan Bielack, Claudia Blattmann, Arndt Borkhardt, Monika Csóka, Wolf Achim Hassenpflug, Edita Kabíčková, Leo Kager, Thorsten Kessler, Christian Peter Kratz, Thomas Kühne et al. · 2022 · European Journal of Cancer
18. Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
    Claudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, Massimo Serra · 2020 · International Journal of Molecular Sciences
19. Advances in Filament Structure of 3D Bioprinted Biodegradable Bone Repair Scaffolds
    Chengxiong Lin, Yaocheng Wang, Zhengyu Huang, Tingting Wu, Weikang Xu, Wenming Wu, Zhibiao Xu · 2021 · International Journal of Bioprinting
20. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
    Pearson, Andrew DJ., Gaspar, Nathalie, Janeway, Katherine, Campbell-Hewson, Quentin, Lawlor, Elizabeth R., Copland, Chris, Karres, Dominik, Norga, Koen, Benzaghou, Fawzi, Weiner, Susan et al. · 2022 · European Journal of Cancer
21. Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs
    K. I. Silver, Sushant Patkar, Christina N. Mazcko, Erika P. Berger, Jessica A. Beck, Amy Kathleen LeBlanc · 2023 · Veterinary and Comparative Oncology
22. Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases
    Jason Eigenbrood, Nathan W. Wong, Paul W. Mallory, Janice S. Pereira, Demond Williams, Douglass W. Morris-II, Jessica A. Beck, James C. Cronk, Carly M. Sayers, Monica Mendez et al. · 2025 · Cancer Research
23. Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights
    Yi Zhang, Shasha Jiang, Jing Lv, Wei Feng, Yan Yu, Heping Zhao · 2025 · Frontiers in Immunology
24. Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
    Éric Thébault, Sophie Piperno-Neumann, Diep Tran, Hélène Pacquement, Perrine Marec‐Bérard, Cyril Lervat, Marie‐Pierre Castex, Morgane Cleirec, Emmanuelle Bompas, Jean‐Pierre Vannier et al. · 2021 · Cancers
25. CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis
    Haoran Kong, Wenhui Yu, Zhuning Chen, Haonan Li, Guiwen Ye, Jiacong Hong, Zhongyu Xie, Keng Chen, Yanfeng Wu, Huiyong Shen · 2021 · Cancer Cell International
26. Calcium-based biomaterials: Unveiling features and expanding applications in osteosarcoma treatment
    Yilun Wu, Min Cheng, Yi Jiang, Xin Zhang, Jiaxiang Li, Yishen Zhu, Qingqiang Yao · 2023 · Bioactive Materials
27. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes
    Qi Wei, Qian Yan, Ming Lv, Delei Song, Xianbin Wang, Kangsong Tian · 2021 · Pathology & Oncology Research
28. The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation
    Shunichi Toki, Tetsuro Yoshimaru, Yosuke Matsushita, Hitoshi Aihara, Masaya Ono, Koichi Tsuneyama, Koichi Sairyo, Toyomasa Katagiri · 2021 · Cancer Science
29. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
    Iseulys Richert, Paul BERCHARD, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jérôme Kerzerho, Martine Caroff et al. · 2023 · Cancers
30. Schottky Heterojunction Facilitates Osteosarcoma Ferroptosis and Enhances Bone Formation in a Switchable Mode
    Zhongyang Lv, Yizhang Wu, Jintao Lin, Weitong Li, Hannah Weisbecker, Peng Wang, Xueru Song, Wei Yan Sun, Ziying Sun, Ya Xie et al. · 2023 · Advanced Functional Materials
31. Bifunctional bone substitute materials for bone defect treatment after bone tumor resection
    Zhule Wang, Ingrid C.M. van der Geest, Sander C.G. Leeuwenburgh, Jeroen J.J.P. van den Beucken · 2023 · Materials Today Bio
32. Expression profile analysis identifies key genes as prognostic markers for metastasis of osteosarcoma
    Xiaoqing Guan, Zhiyuan Guan, 季加孚, Chunli Song · 2020 · Cancer Cell International
33. TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis
    Jie Jiang, Dachang Liu, Guoyong Xu, Tuo Liang, Chaojie Yu, Shian Liao, Liyi Chen, Shengsheng Huang, Xuhua Sun, Ming Yi et al. · 2021 · Frontiers in Oncology
34. Biomineralization-inspired synthesis of amorphous manganese phosphates for GLUT5-targeted drug-free catalytic therapy of osteosarcoma
    Chunlin Zhang, Jianping Hu, Yingying Jiang, Shuo Tan, Kunpeng Zhu, Chao Hui Xue, Yunlu Dai, Feng Chen · 2022 · Nanoscale
35. Children's Oncology Group's 2023 blueprint for research: Bone tumors
    Damon R. Reed, Patrick Joseph Grohar, Elyssa M. Rubin, Odion T. Binitie, Mark Krailo, Jessica L. Davis, Steven G. DuBois, Katherine A. Janeway · 2023 · Pediatric Blood & Cancer
36. Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care
    Rahul Robaish Kumar, Kyle Sporn, Akshay Khanna, Phani Paladugu, Chirag Gowda, Alex Ngo, Ram Jagadeesan, Nasif Zaman, Alireza Tavakkoli · 2025 · Diagnostics
37. Thirty-Day Outcomes following Pediatric Bone and Soft Tissue Sarcoma Surgery: A NSQIP Pediatrics Analysis
    Kathryn E. Gallaway, Junho Ahn, Alexandra K. Callan · 2020 · Sarcoma
38. Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma
    Taiana Campos Leite, Rebecca Jean Watters, Kurt Richard Weiss, Giuseppe Intini · 2021 · Journal of Translational Medicine
39. Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
    Schulte, Brian, Mohindra, Nisha, Milhem, Mohammed, Attia, Steven, Robinson, Steven, Monga, Varun, Hirbe, Angela C., Oppelt, Peter, Charlson, John, Helenowski, Irene et al. · 2021 · British Journal of Cancer
40. Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis – a systematic literature review
    Maria Anna Smolle, Joanna Szkandera, Dimosthenis Andreou, Emanuela Palmerini, Marko Bergovec, Andreas Leithner · 2020 · EFORT Open Reviews
41. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
    Chao Zhang, Haixiao Wu, Guijun Xu, Yao Xu, Wenjuan Ma, Zhijun Li, Jin Zhang · 2023 · BMC Cancer
42. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
    Jianghu Zhou, Fengjun Lan, Miao Liu, Fengyan Wang, Xu Ning, Hua Yang, Hong Sun · 2024 · Frontiers in Pharmacology
43. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma
    Wenhu Li, Xianliao Zhang, Xinhua Xi, Yufa Li, Hong Quan, Shifeng Liu, Liqi Wu, Penghuan Wu, Wenxing Lan, Yongjun Shao et al. · 2020 · Cancer Medicine
44. The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature
    Adit L. Tal, Hiten Doshi, Fauziya Parkar, Tony Abraham, Charito Love, Kenny Q. Ye, Rui Ryan Yang, Bang H. Hoang, David Mark Loeb, Alexander J. Chou et al. · 2020 · Journal of Pediatric Hematology/Oncology
45. A humanised rat model of osteosarcoma reveals ultrastructural differences between bone and mineralised tumour tissue
    Christoph A. Lahr, Marietta Landgraf, Ferdinand Wagner, Amaia Cipitria, Inés Moreno-Jiménez, Onur Bas, Beat Schmutz, Christoph Meinert, Amanda dos Santos Cavalcanti, Tomoji Mashimo et al. · 2021 · Bone
46. Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
    Camille Jubelin, Javier Muñoz-García, Denis Cochonneau, Emilie Moranton, Marie‐Françoise Heymann, Dominique Heymann · 2022 · Cancer Drug Resistance
47. Delay in Diagnosis and Treatment of Bone Sarcoma—Systematic Review
    Dawid Ciechanowicz, Daniel Kotrych, Krzysztof Starszak, Piotr Prowans, Sławomir Zacha, Adam Kamiński, Adam Brodecki, Katarzyna Kotrych · 2025 · Cancers
48. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury
    Sandra Heuschkel, Theresa Kretschmann, Raphael Teipel, Simone von Bonin, Stephan Richter, Susanne Quick, Nael Alakel, Christoph Röllig, Ekaterina Balaian, Frank Kroschinsky et al. · 2021 · Cancer Chemotherapy and Pharmacology
49. TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
    Wei Feng Xu, Yifan Li, Xiaojian Ye, Yunhan Ji, Yu Chen, Xiangyang Zhang, Zhikun Li · 2021 · Cancer Cell International
50. Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature Gaps
    Patrick Basile, Emily Gustava Greengard, Brenda J. Weigel, Logan G. Spector · 2020 · Sarcoma
51. Static Magnetic Field (0.2–0.4 T) Stimulates the Self‐Renewal Ability of Osteosarcoma Stem Cells Through Autophagic Degradation of Ferritin
    Bin Zhao, Tongyao Yu, Shenghang Wang, Jingmin Che, Liangfu Zhou, Peng Shang · 2021 · Bioelectromagnetics
52. Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
    Sarah B. Whittle, Katharine Offer, Ryan David Roberts, Amy Kathleen LeBlanc, Cheryl A. London, Robbie G. Majzner, Alex Yee-Chen Huang, Peter J. Houghton, Alejandro Sweet-Cordero, Patrick Joseph Grohar et al. · 2021 · Pediatric Blood & Cancer
53. Sex differences in osteosarcoma survival across the age spectrum: A National Cancer Database analysis (2004–2016)
    Lindsay A. Williams, Sofia Barragan, Zhanni Lu, Brenda J. Weigel, Logan G. Spector · 2024 · Cancer Epidemiology
54. Osteosarcoma: An Evolving Understanding of a Complex Disease
    John H. Alexander, Odion T. Binitie, George Douglas Letson, David Michael Joyce · 2021 · Journal of the American Academy of Orthopaedic Surgeons
55. First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
    Yan Zhou, Qingcheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian et al. · 2022 · Clinical Cancer Research
56. The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas
    Samuel J. Holzmayer, Kai Liebel, Ilona Hagelstein, Helmut Rainer Salih, Melanie Märklin · 2024 · Frontiers in Immunology
57. Extended analysis of intratumoral heterogeneity of primary osteosarcoma tissue using 3D-in-vivo-tumor-model
    Anna-Lena Feder, Eric Pion, Johannes Troebs, Ulrich Lenze, Lukas Prantl, Maung Mg Htwe, Aung Phyo, Silke Haerteis, Thiha Aung · 2020 · Clinical Hemorheology and Microcirculation
58. AI based diagnostics product design for osteosarcoma cells microscopy imaging of bone cancer patients using CA-MobileNet V3
    Qian Liu, Xing She, Xia Qian · 2024 · Journal of bone oncology
59. Osteosarcoma
    Michael William Bishop · 2025 · Hematology/Oncology Clinics of North America
60. The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells
    Bangmin Wang, Zheping Hong, Chen Zhao, Qing Bi, Junhui Yuan, Jihang Chen, Yi Shen · 2021 · Cancer Cell International
61. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis
    Li-Peng Peng, Jie Li, Xianfeng Li · 2022 · World Journal of Clinical Cases
62. Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
    David Barnes, Peter Dutton, Øyvind Sverre Bruland, Hans A. J. Gelderblom, Ade Faleti, Claudia Bühnemann, Annemiek M. van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love et al. · 2022 · BMC Cancer
63. Current topics and management of head and neck sarcomas
    Kenya Kobayashi, Nobuhiro Hanai, Seiichi Yoshimoto, Yuki Saito, Akihiro Homma · 2023 · Japanese Journal of Clinical Oncology
64. Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
    Jing Zeng, Xianghong Zhang, Zhengjun Lin, Yu Zhang, Jing Yang, Pengcheng Dou, Tang Liu · 2024 · Experimental Hematology and Oncology
65. Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
    Wen-I Chang, Claire Lin, Nicholas R. Liguori, Joshua N. Honeyman, Bradley D. DeNardo, Wafik S. El‐Deiry · 2022 · Frontiers in Pharmacology
66. Surgical Management of Chest Wall Sarcoma
    Nathan W. Mesko, Alejandro Bribriesco, Daniel Philip Raymond · 2020 · Surgical Oncology Clinics of North America
67. Radiomics-based machine learning in prediction of response to neoadjuvant chemotherapy in osteosarcoma: A systematic review and meta-analysis
    Mohsen Salimi, Shakiba Houshi, Ali Gholamrezanezhad, Pouria Vadipour, Sharareh Seifi · 2025 · Clinical Imaging
68. Impact of Surgical Resection and Reasons for Poor Prognosis of Pelvic Osteosarcoma Based on the Bone Tumor Registry in Japan
    Satoshi Takenaka, Hironari Tamiya, Toru Wakamatsu, Sho Nakai, Yoshinori Imura, Hidetatsu Outani, Toshinari Yagi, Akira Kawai · 2021 · Cancers
69. Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma
    Lijun Peng, Huapan Fang, Xiao Jing Yang, Xi Zeng · 2022 · Frontiers in Chemistry
70. Improving Osteosarcoma Treatment: Comparative Oncology in Action
    Lidia Tarone, Katia Mareschi, Elisa Tirtei, Davide Giacobino, Mariateresa Camerino, Paolo Buracco, Emanuela Maria Morello, Federica Cavallo, Federica Riccardo · 2022 · Life
71. The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
    Zhanchao Wang, Huiqiao Wu, Yu Chen, Huajiang Chen, Wen Yuan, Xinwei Wang · 2021 · Journal of Oncology
72. Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications
    Alessandro El Motassime, Raffaele Vitiello, Rocco Maria Comodo, Giacomo Capece, Guido Bocchino, Maria Beatrice Bocchi, Giulio Maccauro, Cesare Meschini · 2025 · Biology
73. Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas
    Charlotte Nazon, Marina Pierrevelcin, Thibault Willaume, Benoît Lhermitte, Noëlle Weingertner, Antonio Di Marco, Laurent Bund, Florence Vincent, Guillaume Bierry, Anne Gomez‐Brouchet et al. · 2022 · Cancers
74. p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma
    Lei Yong, Yan Shi, Hai-Long Wu, Qi-Yuan Dong, Jing Guo, Li-Sheng Hu, Wenhao Wang, Zhi-Ping Guan, Bin-Sheng Yu · 2023 · Frontiers in Oncology
75. Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
    Jordan C. O’Donoghue, Fiona E. Freeman · 2024 · Frontiers in Immunology
76. Li–Fraumeni‐associated osteosarcomas: The French experience
    Émilie Saucier, Gaëlle Bougeard, Anne Gomez‐Brouchet, Catherine Schramm, Rachid Abbas, Pablo Berlanga, Claire Briandet, Marie‐Pierre Castex, Nadège Corradini, Carole Coze et al. · 2024 · Pediatric Blood & Cancer
77. Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
    Natasja Franceschini, Jan Oosting, Maud Tamsma, Bertine Niessen, Inge H. Briaire‐de Bruijn, Brendy van den Akker, Alwine B. Kruisselbrink, Ieva Palubeckaitė, Judith V.M.G. Bovée, Anne‐Marie Cleton-Jansen · 2021 · International Journal of Molecular Sciences
78. Characteristics and outcomes of primary pleural angiosarcoma
    Xia Wang, Zhiqin Lu, Yuxi Luo, Jing Cai, Jianping Wei, Anwen Liu, Zhimin Zeng · 2022 · Medicine
79. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations
    Leonel Pekarek, Basilio José De La Torre-Escuredo, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, David Cobo-Prieto, Luis G. Guijarro, José Vicente Saz, Patricia De Castro-Martinez, Diego Torres‐Carranza et al. · 2022 · International Journal of Molecular Sciences
80. Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care
    Angela Liu, Paige Vicenzi, Ishna Sharma, Kaci Orr, Christa Teller, Micha Koentz, Heidi Trinkman, Kelly Vallance, Anish Ray · 2023 · Hematology Reports
81. Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials
    Emanuela Palmerini, Cristina Meazza, Angela Tamburini, Catalina Márquez-Vega, Gianni Bisogno, Franca Fagioli, Virginia Ferraresi, Giuseppe Maria Milano, Luca Coccoli, Alba Rubio‐San‐Simón et al. · 2025 · Journal of Clinical Oncology
82. Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy
    Lu Xie, Chenglong Chen, Xin Liang, Jie Hua Xu, Xin Sun, Kunkun Sun, Rongli Yang, Xiaodong Tang, Wei Guo · 2022 · Orthopaedic Surgery
83. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction
    Junchao Zhu, Jinghong Yuan, Shahrzad Arya, Du Zhi, Xijuan Liu, Jingyu Jia · 2023 · Frontiers in Immunology
84. From biology to personalized medicine: Recent knowledge in osteosarcoma
    Audrey Mohr, Maria Eugénia Marques Da Costa, Olivia Fromigué, Baptiste Audinot, Thierno Balde, Robin Droit, Samuel D. Abbou, Pierre Khneisser, Pablo Berlanga, Esperanza Pérez et al. · 2024 · European Journal of Medical Genetics
85. Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis
    Niveditha Nerlakanti, J. McGuire, Ryan T. Bishop, Mostafa M Nasr, Tao Li, Damon R. Reed, Conor C. Lynch · 2024 · Cancer Letters
86. Prognostic Factors in Newly Diagnosed High‐Grade Osteosarcoma—A Systematic Review
    Elisa Tirtei, Sascha Wilk Michelsen, Lianne Haveman, Cristina Meazza, Joana Oliveira, Ayesha Rasool, Emanuela Palmerini, Will Wilson, Nathalie Gaspar, Sandra J. Strauss et al. · 2025 · Cancer Medicine
87. New drug candidates for osteosarcoma: Drug repurposing based on gene expression signature
    Raissa Coelho Andrade, Mariana Boroni, Marion Kielmanowicz Amazonas, Fernando Regla Vargas · 2021 · Computers in Biology and Medicine
88. Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group
    Elise Lavit, Mihaela D. Aldea, Sophie Piperno-Neumann, Nelly Firmin, Antoîne Italiano, Nicolás Isambert, Jean‐Emmanuel Kurtz, Corinne Delcambre, Valérie Lebrun, Pauline Soibinet‐Oudot et al. · 2021 · International Journal of Cancer
89. Frequency and reason for reoperation following non-invasive expandable endoprostheses: A systematic review
    Johnathan R. Lex, Amirul Adlan, Kim M. Tsoi, Scott Evans, Jonathan Daniel Stevenson · 2021 · Journal of bone oncology
90. Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response
    Hanna E. Persha, Shumei Kato, Pradip K. De, Jacob J. Adashek, Jason Keith Sicklick, Vivek Subbiah, Razelle Kurzrock · 2022 · Journal of Hematology & Oncology
91. The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
    Lin Hu, Xin Wu, Dongjie Chen, Zhenyu Cao, Zian Li, Yanmin Liu, Qiangqiang Zhao · 2022 · Frontiers in Cell and Developmental Biology
92. Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
    Fleur Kleiburg, Linda Heijmen, Hans A. J. Gelderblom, Szymon M. Kiełbasa, Judith V.M.G. Bovée, Lioe‐Fee de Geus‐Oei · 2023 · British Journal of Radiology
93. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor
    Anthony Bozzo, Caleb Matthew Yeung, Michiel A. J. van de Sande, Michelle A. Ghert, John H. Healey, on behalf of the PARITY Investigators · 2023 · Journal of Bone and Joint Surgery
94. The Nomogram for Early Death in Patients with Bone and Soft Tissue Tumors
    Yao Xu, Guijun Xu, Haixiao Wu, Feng Lin, Min Mao, Vladimir P. Baklaushev, Vladimir Pavlovich Chekhonin, Karl Peltzer, Jun Wang, Guowen Wang et al. · 2020 · Journal of Cancer
95. [Update and interpretation of 2021 National Comprehensive Cancer Network (NCCN) "Clinical Practice Guidelines for Bone Tumors"].
    Ming Ni · 2021 · Europe PMC (PubMed Central)
96. Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model
    Elisa Martella, Barbara Dozza, Claudia Ferroni, Clement Osuru Obeyok, Andrea Guerrini, Daniele Tedesco, Ilse Gert Julia Manet, Giovanna Sotgiu, Marta Columbaro, Marco Ballestri et al. · 2022 · Pharmaceutics
97. Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial
    Audinga‐Dea Hazewinkel, Carlo Lancia, Jakob Anninga, Michiel A. J. van de Sande, Jeremy Simon Whelan, Hans A. J. Gelderblom, Marta F. Fiocco · 2022 · BMJ Open
98. Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study
    Esmee C.M. Kooijmans, Helena J. H. van der Pal, Saskia M. F. Pluijm, Margriet van der Heiden‐van der Loo, Leontien C.M. Kremer, Dorine Bresters, Eline van Dulmen‐den Broeder, Marry M. van den Heuvel‐Eibrink, Jacqueline J. Loonen, Marloes Louwerens et al. · 2022 · Cancers
99. Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single‐cell data
    Zhe Li, Chi Jin, Xinchang Lu, Yan Zhang, Yi Zhang, Jia Wen, Yongkui Liu, Xiaoting Liu, Jiazhen Li · 2023 · The Journal of Gene Medicine
100. The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets
     Linyun Tan, Yitian Wang, Xin Hu, Li Min · 2023 · Biomolecules